Search results for "Pulmonary embolism"


 
Results 51 - 60 of about 102 for "Pulmonary embolism".
Sort by: Relevance | Newest | Oldest

ACP issues best practice advice on evaluating suspected PE

The goal was to provide practical, evidence-based advice for clinicians evaluating adult inpatients and outpatients in whom acute PE is suspected.
https://immattersacp.org/weekly/archives/2015/09/29/1.htm
29 Sep 2015

Wells and Geneva scores evaluated for risk stratification for PE in primary care

Discriminative ability was comparable for the original Wells, modified Wells, simplified Wells, revised Geneva, and simplified revised Geneva models, but the Wells rules had lower failure rates.
https://immattersacp.org/weekly/archives/2015/09/15/1.htm
15 Sep 2015

Extended anticoagulant treatment prevents recurrent VTE after first unprovoked PE

An additional 18 months of warfarin treatment in patients with first unprovoked PE improves outcomes versus placebo, although the improvement was not sustained after anticoagulant treatment was discontinued.
https://immattersacp.org/weekly/archives/2015/07/14/2.htm
14 Jul 2015

Arthroscopic surgery may not benefit patients with degenerative knee disease

Arthroscopic surgery for degenerative knee disease yields “small inconsequential benefit” in middle-aged and older adults and is associated with harms, the authors noted.
https://immattersacp.org/weekly/archives/2015/06/23/1.htm
23 Jun 2015

Top 10 afib pearls manage cardiology's ‘bread and butter’

Atrial fibrillation has been called “the bread and butter” of cardiology, and a condition that impacts all aspects of internal medicine practice.
https://immattersacp.org/archives/2015/06/afib.htm
1 Jun 2015

Approvals for an oral anticoagulant, generic esomeprazole

This update covers the approval of an oral medication to reduce the risk of stroke and embolism in atrial fibrillation and the first generic version of esomeprazole.
https://immattersacp.org/archives/2015/04/fda.htm
1 Apr 2015

MKSAP Quiz: dyspnea in a patient with end-stage COPD

A 72-year-old man is evaluated for dyspnea at rest. He has end-stage COPD and is on a home hospice program. He has weight loss, reduced functional capacity, and muscle atrophy. His medications are ipratropium, salmeterol, fluticasone, albuterol as needed, and prednisone. He is uncomfortable, with chronic air hunger that has gradually increased over the past 2 weeks. Otherwise, his symptoms have been stable without change in cough, sputum production, or fever.
https://immattersacp.org/weekly/archives/2015/02/03/3.htm
3 Feb 2015

NSAID use may be associated with increased VTE risk

There may be a statistically significant increased risk of venous thromboembolism (VTE) among users of nonsteroidal anti-inflammatory drugs (NSAIDs), a meta-analysis found.
https://immattersacp.org/weekly/archives/2014/09/30/4.htm
30 Sep 2014

Systematic review compares new and old anticoagulation options for acute VTE

The benefits and risks of 8 different anticoagulation strategies for patients with venous thromboembolism (VTE), including heparin and new oral anticoagulants, were compared in a large new analysis.
https://immattersacp.org/weekly/archives/2014/09/23/7.htm
23 Sep 2014

Warfarin given to elderly patients within a year of traumatic brain injury associated with net benefit

Resuming warfarin in the year after a traumatic brain injury was associated with a net benefit, due to a reduction in ischemic stroke risk, for elderly patients in a recent study.
https://immattersacp.org/weekly/archives/2014/06/17/5.htm
17 Jun 2014

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next